(Q84491706)
Statements
Bevacizumab, capecitabine, amifostine, and preoperative hypofractionated accelerated radiotherapy (HypoArc) for rectal cancer: a Phase II study (English)
Michael I Koukourakis
Alexandra Giatromanolaki
Pelagia Tsoutsou
Nikolaos Lyratzopoulos
Michael Pitiakoudis
George Kouklakis
Pelagia A Chloropoulou
Kostantinos Manolas
Efthimios Sivridis